Stock listing

Molecure Sa

Selected listing: 1B1 · MUN · EUR · DE

Molecure Sa (Munich:1B1), Health Technology. Latest release Aug 3, 2026: Molecure Receives Positive IDMC Recommendation to Continue the KITE Clinical Trial…

1B1:MUNEURDEUpdated October 2, 2026

Ticker: Munich:1B1
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Munich
Currency: EUR

Latest news from Molecure Sa

Molecure Receives Positive IDMC Recommendation to Continue the KITE Clinical Trial Without Changes to the Study Protocol (OATD-01 Development Program)

August 3, 2026

Strategic update on the progress and development of Molecure's key clinical projects in 2024

March 28, 2025

Avicenna Biosciences and Molecure S.A. Sign Strategic Research Collaboration Agreement to Accelerate Discovery and Development of Small Molecule Drugs

July 31, 2024

Molecure Announces Details for Virtual R&D Day Webcast to be held on Wednesday 7th December 2022

December 6, 2022

All Molecure Sa news →

Research Molecure Sa

Molecure Sa company profile

View the public company page for Molecure Sa on 6ix.

Molecure Sa news

Read company news and market updates connected to Molecure Sa.

Molecure Sa investor events

Find investor webinars, events, and replay context for Molecure Sa.